RECOGNITION OF CLINICAL TRIAL CANCER RESEARCH.pptx

RECOGNITION OF CLINICAL TRIAL CANCER RESEARCH
March 30, 2015
Cancer Center Administrator’s Forum
Lexington, KY
Frederick R. Ueland, MD
Professor and Director
Division of Gynecologic Oncology
University of Kentucky
Background
UK HealthCare leadership understand importance of clinical trial research, are highly supportive and providing funding
Challenge: Design a new system to promote clinical trial participation
Aligned and equitable
Incentivize physicians without direct payments
Standardize ‘Distribution of Effort’ for clinical faculty using the EPAT system (Effort and Productivity Assessment Tool)
Non-sponsored Research
pares clinical productivity (RVUs) to national norms. Based on traditional “academic” metrics: teaching, service and research
23-Jun-18
3
Accrual History at Markey Cancer Center
Dr. Evers hired
EPAT system adopted
NCI-designation
Estimated Accrual- Future Goals
Developing a Novel Systemto Promote Clinical Trial Research
Establish a clinical research fund (CRF) & CRF Oversight Board
Define target activities, method of recognition, quantitate value, assemble variables
Integrate MCC membership rules for clinical research; regular audits of model
Analysis of the current faculty title series structure and mend changes to the Dean
Increased Clinical and Translational Research Effort
Recognizing Research Effort
Define incentive-based model that recognized effort for clinical trial research and aligned the MCC research mission with UK HealthCare strategic goals
What to value?
10% for design and management of investigator-initiated trials (IIT)
10% for trial management including adverse events and regulatory work
80% for patient enrollment
Clinical Research Enrollment and Development of Investigational Trials (CREDIT)
Name CREDIT Board
Establish bylaws, define scope of recognized activities, relative values, and method of measurement
Quarterly meetings
Review metrics, calculate effort, and mend % effort for non-sponsored research to